2023年

発表

  1. Koichiro Wada,Ichiro Tsuboi and Kohei Ogawa：Guidelines for Chlamydia trachomatis．The Asian UTI/STI Forum 2023 (AAUS-KAUTII Conjoined Symposium)．Suwon, Korea，2023.7
  2. Koichiro Wada,Ichiro Tsuboi and Kohei Ogawa：Antibiotic treatment for M. genitalium and non-chlamydial non-gonococcal urethritis．The 19th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI 2023)．Seoul, Korea，2023.7
  3. 和田耕一郎：島根大学泌尿器科の現状と展望．第334回日本泌尿器科学会岡山地方会（特別講演）．Web，2023.2
  4. 和田耕一郎,田中元,三谷一貴,原尚史,吉岡彩織,坪井一朗,小林祐介,中島宏親,小川貢平,永見太一,小池千明,椎名浩昭：本邦におけるMycoplasma genitalium感染症の現状と課題．日本性感染症学会 第36回学術大会（シンポジウム）．東京，2023.12
  5. 和田耕一郎：JAID/JSC感染症治療ガイド2023 ー尿路性器感染症－．第75回西日本泌尿器科学会（卒後教育プログラム）．松山，2023.11
  6. 和田耕一郎,坪井一朗,田中元,三谷一貴,吉岡彩織,横山周平,小林祐介,中島宏親,永見太一,小川貢平,小池千明,本田聡,椎名浩昭：尿路合併症を生じた献腎移植レシピエントの2例．第336回日本泌尿器科学会岡山地方会．岡山，2023.9
  7. 和田耕一郎,山本新吾（兵庫医科大学泌尿器科）,高橋聡（札幌医科大学医学部感染制御・臨床検査医学講座）：第12回三学会合同抗菌薬感受性サーベイランスの結果報告 ー単純性膀胱炎2020年ー．第34回日本臨床微生物学会総会・学術集会．横浜，2023.2
  8. 和田耕一郎：腎移植後の尿路性器感染症に対する予防とマネジメント．第56回日本臨床腎移植学会（シンポジウム）．東京，2023.2
  9. 和田耕一郎：腎移植について．腎代替療法webセミナー．Web，2023.9
  10. 和田耕一郎,竹谷健,岩下義明,京哲（島根大学）,尾花和子（埼玉医科大学）,渥美治世（東海大学）,安達知子,種部恭子（日本産婦人科医会理事）,今井伸（聖隷浜松病院）,山田浩史（なごやなごみ）,河野美江（島根大学）：性暴力被害者支援に関する全国医師調査．「DV・性暴力被害者の医療と連携した支援体制の構築のための研究」中間報告会．東京，2023.7
  11. 和田耕一郎,小川貢平,坪井一朗,田中元,三谷一貴,吉岡彩織,横山周平,小林祐介,永見太一,中島宏親,小池千明：Prevention of adverse events in procedures for urinary calculi．第110回日本泌尿器科学会総会（JUA/AUAジョイントシンポジウム）．神戸，2023.4
  12. 和田耕一郎,小川貢平,坪井一朗,田中元,三谷一貴,吉岡彩織,横山周平,小林祐介,永見太一,中島宏親,小池千明：Guidelines for catheter-associated urinary tract infection and urosepsis．The 110th Annual Meeting of the JUA（JUA/AUA Joint Symposium）．神戸，2023.4
  13. 和田耕一郎：尿路性器感染症．第97回日本感染症学会総会・学術講演会／第71回日本化学療法学会学術集会 合同学会（JaSAジョイントシンポジウム）．横浜，2023.4
  14. 和田耕一郎,山本新吾（兵庫医科大学泌尿器科）,高橋聡（札幌医科大学医学部感染制御・臨床検査医学講座）：第12回三学会合同抗菌薬感受性サーベイランスの結果報告 ー単純性膀胱炎2020年ー．第97回日本感染症学会総会・学術講演会／第71回日本化学療法学会学術集会 合同学会．横浜，2023.2
  15. 和田耕一郎：本邦におけるM. genitalium感染症の現状と課題．第13回日本性感染症学会中国四国支部総会．岡山，2023.1

論文

  1. Mitani K, Tsuboi I, Tanaka G, Yosioka S, Yokoyama S, Kobayashi Y, Nakajima H, Nagami T, Ogawa K, Wada K: Metastatic small cell bladder cancer treated with sequential systemic therapy including pembrolizumab and amrubicin: A case report.
    IJU Case Rep. 2023 Dec 19;7(2):127-130.
  2. Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y; Japanese Urological Oncology Group: Prognostic impact of histological discordance between transurethral resection and radical cystectomy. BJU Int. 2024 Aug;134(2):207-218.
  3. Shokei S, Nagase M, Araki A, Nakajima H, Wada K, Niino D: A Case Report of Carcinoid with Teratoma Arising from the Renal Hilum. Int J Surg Pathol. 2024 Oct;32(7):1389-1397.
  4. Wada K, Tsuboi I, Takahashi S, Yasuda M, Miyazaki J, Kobayashi K, Matsumoto M, Hayami H, Yamamoto S, Kiyota H, Sato J, Matsumoto T, Hasegawa N, Kobayashi I, Masumori N, Kimura T, Yamada H, Matsumoto K, Ishikawa K, Fujimoto K, Shigemura K, Sadahira T, Ito K, Yokoyama T, Izumitani M, Sumii T, Hosobe T, Hikosaka K, Kawahara M, Sato T, Ito S, Masue N, Sakurai T, Kokura K, Kadena H, Morikawa T, Minamidate Y, Yoh M, Hashimoto J, Maruyama T, Yoshioka M, Takashima K, Kawai S, Nishi S, Matsumoto T, Hirayama H, Okusa H, Uno S, Inoue Y, Kurimura Y, Shirane T, Takaoka E, Tojo T, Arakawa S, Hamasuna R, Tomioka A, Iihara K, Ishitoya S, Maeda H, Terado M: Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus. J Infect Chemother. 2024 Apr;30(4):277-285.
  5. Tanaka G, Tsuboi I, Mitani K, Yoshioka S, Yokoyama S, Kobayashi Y, Nakajima H, Nagami T, Ogawa K, Wada K: Bladder stone formation around polyethylene glycol after use of SpaceOAR Hydrogel. IJU Case Rep. 2023 Aug 18;6(6):353-356.
  6. Katayama S, Iwata T, Kawada T, Okamoto Y, Sano Y, Kawago Y, Miyake S, Moriwake T, Kuinose A, Horikawa Y, Tsuboi K, Tsuboi I, Sakaeda K, Nakatsuka H, Takamoto A, Hirata T, Shirasaki Y, Yamasaki T, Morinaka H, Nagasaki N, Hara T, Ochi A, Okumura M, Watanabe T, Sekito T, Kawano K, Horii S, Yamanoi T, Nagao K, Yoshinaga K, Maruyama Y, Tominaga Y, Sadahira T, Nishimura S, Edamura K, Kobayashi T, Kusumi N, Kurose K, Yamamoto Y, Sugimoto M, Nakada T, Sasaki K, Takenaka T, Ebara S, Miyaji Y, Wada K, Kobayashi Y, Araki M: Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab. Urol Oncol. 2024 Mar;42(3):70.e11-70.e18.
  7. Tsuboi I, Ogawa K, Wada K: Editorial Comment to “Assistent guide short: A new device for facilitating ureteric stenting in women”. Int J Urol. 2023 Nov;30(11):1053.
  8. Sakaeda K, Sadahira T, Maruyama Y, Iwata T, Watanabe M, Wada K, Araki M: The Genotypic and Phenotypic Characteristics Contributing to Flomoxef Sensitivity in Clinical Isolates of ESBL-Producing E. coli Strains from Urinary Tract Infections. Antibiotics (Basel). 2023 Mar 6;12(3):522.
  9. Sekito T, Wada K, Ishii A, Iwata T, Matsubara T, Tomida S, Watanabe M, Araki M, Sadahira T: Etiology of recurrent cystitis in postmenopausal women based on vaginal microbiota and the role of Lactobacillus vaginal suppository. Front Microbiol. 2023 May 18;14:1187479.
  10. Tsuboi I, Ogawa K, Kadota K, Kishi T, Kawabata Y, Wada K: Right adrenal giant cystic pheochromocytoma: A case report. Urol Case Rep. 2023 Apr 5;48:102398.
  11. Yasuda M, Takahashi S, Miyazaki J, Wada K, Kobayashi K, Matsumoto M, Hayami H, Yamamoto S, Kiyota H, Sato J, Matsumoto T, Yotsuyanagi H, Hanaki H, Masumori N, Hiyama Y, Nishiyama H, Kimura T, Yamada H, Matsumoto K, Ishikawa K, Togo Y, Tanaka K, Sadahira T, Inokuchi J, Hamasuna R, Ito K, Hirayama H, Hayashi K, Kurimura Y, Kadena H, Ito S, Shiono Y, Maruyama T, Ito M, Hatano K, Chokyu H, Ihara H, Uno S, Monden K, Yokoyama T, Kano M, Kaji S, Kawahara M, Sumii T, Tojo T, Hosobe T, Naito K, Kawai S, Nishimura H, Izumitani M, Yoh M, Matsumura M, Fujita R, Takayama K, Hara M, Nishi S: The third nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2016-2017. J Infect Chemother. 2023 Nov;29(11):1011-1016.
  12. Tsuboi I, Yokoyama S, Nakajima H, Yosioka S, Kobayashi Y, Nagami T, Ogawa K, Wada K: Cut-to-the-light technique is useful for complete obstruction of a Wallace ureteroileal anastomosis. IJU Case Rep. 2023 Feb 3;6(2):154-156.
  13. Matsumoto J, Nishimoto A, Watari S, Ueki H, Shiromizu S, Iwata N, Takeda T, Ushio S, Kajizono M, Fujiyoshi M, Koyama T, Araki M, Wada K, Zamami Y, Nasu Y, Ariyoshi N: Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Mol Cell Biochem. 2023 Aug;478(8):1779-1790.
  14. Minami K, Osawa T, Kojima T, Hara T, Eto M, Takeuchi A, Nakai Y, Ueda K, Ozawa M, Uemura M, Ohba K, Tamura K, Shindo T, Nakagomi H, Takahashi A, Anai S, Yokomizo A, Morizane S, Kimura T, Shimazui T, Miyauchi Y, Mitsuzuka K, Hara H, Yoshimura K, Shiina H, Ito YM, Murai S, Nishiyama H, Shinohara N, Kitamura H; Japanese Urological Oncology Group: Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment. Urol Oncol. 2023 Nov;41(11):458.e9-458.e19.
  15. Bekku K, Nagasaki N, Tsuboi I, Takamoto A, Katayama S, Araki M: Tolerability of immune checkpoint inhibitor doublet for advanced renal cell carcinoma patients with pre-dialysis chronic kidney disease or end-stage renal disease. Int J Urol. 2023 Oct;30(10):931-933.